Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Persigehl

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
Cancer Medicine|May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessmentLucia Nogova, Christian Mattonet, Matthias Scheffler, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Standardization of a CT Protocol for Imaging Patients with Suspected COVID-19-A RACOON ProjectAndrea Steuwe, Benedikt Kamp, Saif Afat, et al.
European Radiology|July 9, 2008
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trialBernd Tombach, Klaus Bohndorf, Wolfgang Brodtrager, et al.
Nature Communications|December 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progressionAriadne Androulidaki, Fanyu Liu, Christina M Bebber, et al.
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Cancer Medicine|May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessmentLucia Nogova, Christian Mattonet, Matthias Scheffler, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Standardization of a CT Protocol for Imaging Patients with Suspected COVID-19-A RACOON ProjectAndrea Steuwe, Benedikt Kamp, Saif Afat, et al.
European Radiology|July 9, 2008
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trialBernd Tombach, Klaus Bohndorf, Wolfgang Brodtrager, et al.
Nature Communications|December 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progressionAriadne Androulidaki, Fanyu Liu, Christina M Bebber, et al.
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Pageof 20